135 related articles for article (PubMed ID: 12408725)
1. Synthesis and evaluation of no-carrier-added 8-cyclopentyl-3-(3-[(18)F]fluoropropyl)-1-propylxanthine ([(18)F]CPFPX): a potent and selective A(1)-adenosine receptor antagonist for in vivo imaging.
Holschbach MH; Olsson RA; Bier D; Wutz W; Sihver W; Schüller M; Palm B; Coenen HH
J Med Chem; 2002 Nov; 45(23):5150-6. PubMed ID: 12408725
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of 18F-CPFPX, a novel adenosine A1 receptor ligand: in vitro autoradiography and high-resolution small animal PET.
Bauer A; Holschbach MH; Cremer M; Weber S; Boy C; Shah NJ; Olsson RA; Halling H; Coenen HH; Zilles K
J Nucl Med; 2003 Oct; 44(10):1682-9. PubMed ID: 14530487
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Pharmacological Evaluation of Identified and Putative Metabolites of the A
Holschbach MH; Bier D; Sihver W; Schulze A; Neumaier B
ChemMedChem; 2017 May; 12(10):770-784. PubMed ID: 28217962
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and preliminary evaluation of [11C]KF15372, a selective adenosine A1 antagonist.
Ishiwata K; Furuta R; Shimada J; Ishii S; Endo K; Suzuki F; Senda M
Appl Radiat Isot; 1995 Oct; 46(10):1009-13. PubMed ID: 7496369
[TBL] [Abstract][Full Text] [Related]
5. In vivo imaging of adenosine A1 receptors in the human brain with [18F]CPFPX and positron emission tomography.
Bauer A; Holschbach MH; Meyer PT; Boy C; Herzog H; Olsson RA; Coenen HH; Zilles K
Neuroimage; 2003 Aug; 19(4):1760-9. PubMed ID: 12948730
[TBL] [Abstract][Full Text] [Related]
6. 8-Bicycloalkyl-CPFPX derivatives as potent and selective tools for in vivo imaging of the A
Humpert S; Schneider D; Bier D; Schulze A; Neumaier F; Neumaier B; Holschbach M
Eur J Med Chem; 2024 May; 271():116380. PubMed ID: 38615410
[TBL] [Abstract][Full Text] [Related]
7. In vivo kinetic and steady-state quantification of 18F-CPFPX binding to rat cerebral A1 adenosine receptors: validation by displacement and autoradiographic experiments.
Elmenhorst D; Kroll T; Wedekind F; Weisshaupt A; Beer S; Bauer A
J Nucl Med; 2013 Aug; 54(8):1411-9. PubMed ID: 23740103
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and preliminary evaluation of [11C]KF17837, a selective adenosine A2A antagonist.
Ishiwata K; Noguchi J; Toyama H; Sakiyama Y; Koike N; Ishii S; Oda K; Endo K; Suzuki F; Senda M
Appl Radiat Isot; 1996; 47(5-6):507-11. PubMed ID: 8673072
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of the A(1)1 adenosine receptor positron emission tomography ligand [18F]8-cyclopentyl-3-(3-fluoropropyl)-1-propylxanthine ([18F]CPFPX) in rodents and humans.
Bier D; Holschbach MH; Wutz W; Olsson RA; Coenen HH
Drug Metab Dispos; 2006 Apr; 34(4):570-6. PubMed ID: 16415116
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of radioiodinated 8-Cyclopentyl-3-[(E)-3-iodoprop-2-en-1-yl]-1-propylxanthine ([*I]CPIPX) as a new potential A1 adenosine receptor antagonist for SPECT.
Sihver W; Holschbach MH; Bier D; Wutz W; Schulze A; Olsson RA; Coenen HH
Nucl Med Biol; 2003 Aug; 30(6):661-8. PubMed ID: 12900292
[TBL] [Abstract][Full Text] [Related]
11. New potent A
Kreft S; Bier D; Holschbach MH; Schulze A; Coenen HH
Nucl Med Biol; 2017 Jan; 44():69-77. PubMed ID: 27821347
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate.
Chattopadhyay S; Xue B; Collins D; Pichika R; Bagnera R; Leslie FM; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
J Nucl Med; 2005 Jan; 46(1):130-40. PubMed ID: 15632043
[TBL] [Abstract][Full Text] [Related]
13. Influence of binding affinity and blood plasma level on cerebral pharmacokinetics and PET imaging characteristics of two novel xanthine PET radioligands for the A
Schneider D; Oskamp A; Holschbach M; Neumaier B; Bier D; Bauer A
Nucl Med Biol; 2020; 82-83():1-8. PubMed ID: 31838339
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of [11C]FR194921 as a nonxanthine-type PET tracer for adenosine A1 receptors in the brain.
Matsuya T; Takamatsu H; Murakami Y; Noda A; Ichise R; Awaga Y; Nishimura S
Nucl Med Biol; 2005 Nov; 32(8):837-44. PubMed ID: 16253808
[TBL] [Abstract][Full Text] [Related]
15. Caffeine occupancy of human cerebral A1 adenosine receptors: in vivo quantification with 18F-CPFPX and PET.
Elmenhorst D; Meyer PT; Matusch A; Winz OH; Bauer A
J Nucl Med; 2012 Nov; 53(11):1723-9. PubMed ID: 22966134
[TBL] [Abstract][Full Text] [Related]
16. Efficient radiosynthesis of 2-[(18)f]fluoroadenosine: a new route to 2-[(18)f]fluoropurine nucleosides.
Marchand P; Lorilleux C; Gilbert G; Gourand F; Sobrio F; Peyronnet D; Dhilly M; Barré L
ACS Med Chem Lett; 2010 Sep; 1(6):240-3. PubMed ID: 24900201
[TBL] [Abstract][Full Text] [Related]
17. In vivo biodistribution of [N-11C-methyl]KF 17837 using 3-D-PET: evaluation as a ligand for the study of adenosine A2A receptors.
Stone-Elander S; Thorell JO; Eriksson L; Fredholm BB; Ingvar M
Nucl Med Biol; 1997 Feb; 24(2):187-91. PubMed ID: 9089711
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vivo evaluation of novel PET radioligands for imaging the endothelin-A receptor.
Mathews WB; Murugesan N; Xia J; Scheffel U; Hilton J; Ravert HT; Dannals RF; Szabo Z
J Nucl Med; 2008 Sep; 49(9):1529-36. PubMed ID: 18703610
[TBL] [Abstract][Full Text] [Related]
19. A1 adenosine receptor antagonists as ligands for positron emission tomography (PET) and single-photon emission tomography (SPET).
Holschbach MH; Fein T; Krummeich C; Lewis RG; Wutz W; Schwabe U; Unterlugauer D; Olsson RA
J Med Chem; 1998 Feb; 41(4):555-63. PubMed ID: 9484505
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
